ANIP Stock Summary and Trading Ideas (Ani Pharmaceuticals | NASDAQ:ANIP)

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Ani Pharmaceuticals trades on the NASDAQ stock market under the symbol ANIP.

As of August 28, 2026, ANIP stock price declined to $72.83 with 348,287 million shares trading.

ANIP has a beta of 0.50, meaning it tends to be less sensitive to market movements. ANIP has a correlation of 0.04 to the broad based SPY ETF.

ANIP has a market cap of $1.67 billion. This is considered a Small Cap stock.

Last quarter Ani Pharmaceuticals reported $266 million in Revenue and $2.21 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.27.

In the last 3 years, ANIP traded as high as $99.50 and as low as $48.20.

The top ETF exchange traded funds that ANIP belongs to (by Net Assets): IJR, VTI, AVUV, IWM, VXF.

ANIP has underperformed the market in the last year with a price return of -21.3% while the SPY ETF gained +19.7%. ANIP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.2% and -4.8%, respectively, while the SPY returned +2.2% and -0.9%, respectively.

ANIP support price is $72.00 and resistance is $75.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIP shares will trade within this expected range on the day.